Staar Surgical reported $45.3M in Gross Profit on Sales for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Abbott ABT:US $ 6505M 1225M
Atrion ATRI:US 17.79M 77K
Boston Scientific BSX:US $ 2018M 102M
Cerus CERS:US $ 24.52M 2.08M
Cooper Companies COO:US $ 516.1M 29M
Exact Sciences EXAS:US $ 340.64M 19.79M
Hologic HOLX:US $ 828.1M 126.5M
Johnson & Johnson JNJ:US $ 16088M 343M
Meridian Bioscience VIVO:US $ 44.72M 7.61M
Merit Medical Systems MMSI:US $ 120.49M 3.64M
Novartis NOVN:VX 9.52B 21M
Orasure Technologies OSUR:US $ 21.47M 9.2M
Orthofix International OFIX:US $ 84.12M 9.83M
Rockwell Medical RMTI:US $ -0.33M 0.07M
Sientra SIEN:US 10.59M 675K
Staar Surgical STAA:US $ 45.3M 3.9M
Valeant Pharmaceuticals VRX:CN $ 1529M 41M